Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Our AI scores Cibus, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Cibus, Inc. is a small-cap company with a market capitalization of $87M. It ranks number 7 by market capitalization among the 12 Agricultural Chemicals issuers in our coverage with a current forecast. Its Net Margin of -3827.8% is the lowest of the 8 peers that report one.
For CBUS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -18.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CBUS included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Agricultural Chemicals peers listed below that report each metric.
| Metric | CBUS | Rank |
|---|---|---|
| Market Cap | $87M | 7/12 |
| P/B Ratio | 1.73x | 2/5 |
| EPS | $-1.12 | – |
| Book Value/Share | $0.66 | – |
| Revenue/Share | $0.06 | – |
| FCF/Share | $-0.61 | – |
| Metric | CBUS | Rank |
|---|---|---|
| ROE | -186.8% | 5/5 |
| Operating Margin | -2563.3% | 11/11 |
| Net Margin | -3827.8% | 8/8 |
| EBT Margin | -4049.0% | 11/11 |
| Tax Rate | -0.0% | – |
| Metric | CBUS | Rank |
|---|---|---|
| Current Ratio | 1.62x | 6/11 |
| D/E Ratio | 5.52x | 2/8 |
| Interest Coverage | -1292.5x | 7/7 |
| Working Capital | $9M | 9/11 |
| Metric | CBUS | Rank |
|---|---|---|
| Operating Cash Flow | -$46M | 11/12 |
| Free Cash Flow | -$46M | 7/9 |
| Capital Spending | -$270K | 2/9 |
| FCF/Sales | -1065.6% | 9/9 |
| CapEx/Sales | 6.1% | 6/9 |
| Metric | CBUS | Rank |
|---|---|---|
| Receivables Turnover | 5.2x | 6/8 |
| Fixed Assets Turnover | 0.9x | 9/10 |
| Days Sales Outstanding | 70 days | 3/8 |
| Metric | CBUS | Rank |
|---|---|---|
| Total Revenue | $4M | 10/11 |
| Operating Income | -$63M | 10/12 |
| Net Income | -$94M | 8/8 |
| R&D Expense | $37M | 3/7 |
| SG&A Expense | $21M | 8/8 |
| Metric | CBUS | Rank |
|---|---|---|
| Shares Outstanding | 76M | – |
| Total Current Assets | $23M | 7.1% of assets |
| Cash & Short-term Investments | $20M | 6.2% of assets |
| Accounts Receivable | $840K | 0.3% of assets |
| Total Liabilities | $278M | 84.2% of assets |
| Short-term Debt | $9M | 2.7% of assets |
Companies classified under the same SEC industry code as Cibus, Inc. (Agricultural Chemicals): 12 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CBUS Cibus, Inc. | $87M | |
| NTR Nutrien Ltd. | $35.12B | |
| CF Cf Industries Holdings, Inc. | $18.07B | |
| MOS Mosaic Co | $7.11B | |
| ICL Icl Group Ltd. | $6.04B | |
| SMG Scotts Miracle-Gro Co | $3.86B | |
| UAN Cvr Partners, Lp | $1.16B | |
| AVD American Vanguard Corp | $28M | |
| BIOX Bioceres Crop Solutions Corp. | $15M | |
| BNET Bion Environmental Technologies Inc | $11M | |
| SNES Senestech, Inc. | $6M | |
| EVGN Evogene Ltd. | $5M |
Cibus, Inc., a leading agricultural biotechnology firm, announced that Co-Founder and Interim CEO Peter Beetham will present at the AGP Annual Virtual Healthcare Company Showcase on May 21, 2025. He ...
Cibus, Inc. (NASDAQ:CBUS) Q1 2026 Earnings Call Transcript May 14, 2026Cibus, Inc. misses on earnings expectations. Reported EPS is $-0.33 EPS, expectations were $-0.27. Cibus, Inc. (NASDAQ:CBUS) Q4 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Our AI scores Cibus, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For CBUS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -18.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Cibus, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
12 issuers in our coverage, CBUS included, share the SEC industry code Agricultural Chemicals. The largest are: Nutrien Ltd. (NTR), Cf Industries Holdings, Inc. (CF), Mosaic Co (MOS), Icl Group Ltd. (ICL), Scotts Miracle-Gro Co (SMG), Cvr Partners, Lp (UAN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
